Literature DB >> 15355978

Adenomatous polyposis coli is down-regulated by the ubiquitin-proteasome pathway in a process facilitated by Axin.

Jongkyu Choi1, Sun Young Park, Frank Costantini, Eek-Hoon Jho, Choun-Ki Joo.   

Abstract

Adenomatous polyposis coli (APC) protein and Axin form a complex that mediates the down-regulation of beta-catenin, a key effector of Wnt signaling. Truncation mutations in APC are responsible for familial and sporadic colorectal tumors due to failure in the down-regulation of beta-catenin. While the regulation of beta-catenin by APC has been extensively studied, the regulation of APC itself has received little attention. Here we show that the level of APC is down-regulated by the ubiquitin-proteasome pathway and that Wnt signaling inhibits the process. The domain responsible for the down-regulation and direct ubiquitination was identified. We also show an unexpected role for Axin in facilitating the ubiquitination-proteasome-mediated down-regulation of APC through the oligomerization of Axin. Our results suggest a new mechanism for the regulation of APC by Axin and Wnt signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15355978     DOI: 10.1074/jbc.M404655200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  The various roles of ubiquitin in Wnt pathway regulation.

Authors:  Daniele V F Tauriello; Madelon M Maurice
Journal:  Cell Cycle       Date:  2010-09-25       Impact factor: 4.534

2.  Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines.

Authors:  Bradley W Doble; Satish Patel; Geoffrey A Wood; Lisa K Kockeritz; James R Woodgett
Journal:  Dev Cell       Date:  2007-06       Impact factor: 12.270

3.  Trabid, a new positive regulator of Wnt-induced transcription with preference for binding and cleaving K63-linked ubiquitin chains.

Authors:  Hoanh Tran; Fumihiko Hamada; Thomas Schwarz-Romond; Mariann Bienz
Journal:  Genes Dev       Date:  2008-02-15       Impact factor: 11.361

Review 4.  Wnt/beta-catenin signaling: components, mechanisms, and diseases.

Authors:  Bryan T MacDonald; Keiko Tamai; Xi He
Journal:  Dev Cell       Date:  2009-07       Impact factor: 12.270

5.  The ubiquitin-specific protease USP34 regulates axin stability and Wnt/β-catenin signaling.

Authors:  Tony T H Lui; Celine Lacroix; Syed M Ahmed; Seth J Goldenberg; Craig A Leach; Avais M Daulat; Stephane Angers
Journal:  Mol Cell Biol       Date:  2011-03-07       Impact factor: 4.272

6.  Molecular Role of RNF43 in Canonical and Noncanonical Wnt Signaling.

Authors:  Tadasuke Tsukiyama; Akimasa Fukui; Sayuri Terai; Yoichiro Fujioka; Keisuke Shinada; Hidehisa Takahashi; Terry P Yamaguchi; Yusuke Ohba; Shigetsugu Hatakeyama
Journal:  Mol Cell Biol       Date:  2015-03-30       Impact factor: 4.272

7.  Reversible modification of adenomatous polyposis coli (APC) with K63-linked polyubiquitin regulates the assembly and activity of the β-catenin destruction complex.

Authors:  Hoanh Tran; Paul Polakis
Journal:  J Biol Chem       Date:  2012-07-03       Impact factor: 5.157

8.  The Poly(ADP-ribose) Polymerase Enzyme Tankyrase Antagonizes Activity of the β-Catenin Destruction Complex through ADP-ribosylation of Axin and APC2.

Authors:  Heather E Croy; Caitlyn N Fuller; Jemma Giannotti; Paige Robinson; Andrew V A Foley; Robert J Yamulla; Sean Cosgriff; Bradford D Greaves; Ryan A von Kleeck; Hyun Hyung An; Catherine M Powers; Julie K Tran; Aaron M Tocker; Kimberly D Jacob; Beckley K Davis; David M Roberts
Journal:  J Biol Chem       Date:  2016-04-11       Impact factor: 5.157

Review 9.  Mechanisms of Wnt signaling and control.

Authors:  Stephanie Grainger; Karl Willert
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2018-03-30

10.  XRab40 and XCullin5 form a ubiquitin ligase complex essential for the noncanonical Wnt pathway.

Authors:  Rebecca Hui Kwan Lee; Hidekazu Iioka; Masato Ohashi; Shun-Ichiro Iemura; Tohru Natsume; Noriyuki Kinoshita
Journal:  EMBO J       Date:  2007-07-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.